578 related articles for article (PubMed ID: 12074047)
1. Dendritic cells cultured in anti-CD40 antibody-immobilized plates elicit a highly efficient peptide-specific T-cell response.
Osada T; Nagawa H; Takahashi T; Tsuno NH; Kitayama J; Shibata Y
J Immunother; 2002; 25(2):176-84. PubMed ID: 12074047
[TBL] [Abstract][Full Text] [Related]
2. Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicity.
Kalady MF; Onaitis MW; Emani S; Abdel-Wahab Z; Tyler DS; Pruitt SK
J Surg Res; 2004 Jan; 116(1):24-31. PubMed ID: 14732346
[TBL] [Abstract][Full Text] [Related]
3. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
[TBL] [Abstract][Full Text] [Related]
4. Preparation of fully activated dendritic cells capable of priming tumor-specific cytotoxic T lymphocytes in patients with metastatic cancer using penicillin-killed streptococcus pyogenes (OK432) and anti-CD40 antibody.
Kontani K; Teramoto K; Ozaki Y; Sawai S; Tezuka N; Ishida H; Kajino K; Fujino S; Yamauchi A; Taguchi O; Kannagi R; Yokomise H; Ogasawara K
Oncol Rep; 2007 Apr; 17(4):895-902. PubMed ID: 17342333
[TBL] [Abstract][Full Text] [Related]
5. CD1-mediated gamma/delta T cell maturation of dendritic cells.
Leslie DS; Vincent MS; Spada FM; Das H; Sugita M; Morita CT; Brenner MB
J Exp Med; 2002 Dec; 196(12):1575-84. PubMed ID: 12486100
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of agonistic anti-CD40 on human mature and immature dendritic cells: the Janus face of anti-CD40.
de Goër de Herve MG; Durali D; Tran TA; Maigné G; Simonetta F; Leclerc P; Delfraissy JF; Taoufik Y
Blood; 2005 Oct; 106(8):2806-14. PubMed ID: 15994291
[TBL] [Abstract][Full Text] [Related]
7. Potent maturation of monocyte-derived dendritic cells after CD40L lentiviral gene delivery.
Koya RC; Kasahara N; Favaro PM; Lau R; Ta HQ; Weber JS; Stripecke R
J Immunother; 2003; 26(5):451-60. PubMed ID: 12973034
[TBL] [Abstract][Full Text] [Related]
8. A subset of human monocyte-derived dendritic cells expresses high levels of interleukin-12 in response to combined CD40 ligand and interferon-gamma treatment.
Mosca PJ; Hobeika AC; Clay TM; Nair SK; Thomas EK; Morse MA; Lyerly HK
Blood; 2000 Nov; 96(10):3499-504. PubMed ID: 11071647
[TBL] [Abstract][Full Text] [Related]
9. Fusion of Bacterial Flagellin to a Dendritic Cell-Targeting αCD40 Antibody Construct Coupled With Viral or Leukemia-Specific Antigens Enhances Dendritic Cell Maturation and Activates Peptide-Responsive T Cells.
Schmitt S; Tahk S; Lohner A; Hänel G; Maiser A; Hauke M; Patel L; Rothe M; Josenhans C; Leonhardt H; Griffioen M; Deiser K; Fenn NC; Hopfner KP; Subklewe M
Front Immunol; 2020; 11():602802. PubMed ID: 33281829
[TBL] [Abstract][Full Text] [Related]
10. The influence of CD40 ligation and interferon-gamma on functional properties of human monocyte-derived dendritic cells activated with polyinosinic-polycytidylic acid.
Dragicević A; Dzopalić T; Vasilijić S; Vucević D; Bozić B; Majstorović I; Balint B; Colić M
Vojnosanit Pregl; 2011 Apr; 68(4):301-8. PubMed ID: 21627015
[TBL] [Abstract][Full Text] [Related]
11. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation.
Fujii S; Liu K; Smith C; Bonito AJ; Steinman RM
J Exp Med; 2004 Jun; 199(12):1607-18. PubMed ID: 15197224
[TBL] [Abstract][Full Text] [Related]
12. The duration of signaling through CD40 directs biological ability of dendritic cells to induce antitumor immunity.
Watanabe S; Kagamu H; Yoshizawa H; Fujita N; Tanaka H; Tanaka J; Gejyo F
J Immunol; 2003 Dec; 171(11):5828-36. PubMed ID: 14634092
[TBL] [Abstract][Full Text] [Related]
13. Calcium signaling inhibits interleukin-12 production and activates CD83(+) dendritic cells that induce Th2 cell development.
Faries MB; Bedrosian I; Xu S; Koski G; Roros JG; Moise MA; Nguyen HQ; Engels FH; Cohen PA; Czerniecki BJ
Blood; 2001 Oct; 98(8):2489-97. PubMed ID: 11588047
[TBL] [Abstract][Full Text] [Related]
14. Mycobacterium leprae infection in monocyte-derived dendritic cells and its influence on antigen-presenting function.
Hashimoto K; Maeda Y; Kimura H; Suzuki K; Masuda A; Matsuoka M; Makino M
Infect Immun; 2002 Sep; 70(9):5167-76. PubMed ID: 12183567
[TBL] [Abstract][Full Text] [Related]
15. Combination of monocyte-derived dendritic cells and activated T cells which express CD40 ligand: a new approach to cancer immunotherapy.
Sato T; Terai M; Yasuda R; Watanabe R; Berd D; Mastrangelo MJ; Hasumi K
Cancer Immunol Immunother; 2004 Jan; 53(1):53-61. PubMed ID: 13680192
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide modulation of dendritic cells is insufficient to mature dendritic cells to generate CTLs from naive polyclonal CD8+ T cells in vitro, whereas CD40 ligation is essential.
Kelleher M; Beverley PC
J Immunol; 2001 Dec; 167(11):6247-55. PubMed ID: 11714787
[TBL] [Abstract][Full Text] [Related]
17. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
[TBL] [Abstract][Full Text] [Related]
18. Effect of oxygen levels on the physiology of dendritic cells: implications for adoptive cell therapy.
Futalan D; Huang CT; Schmidt-Wolf IG; Larsson M; Messmer D
Mol Med; 2011; 17(9-10):910-6. PubMed ID: 21647537
[TBL] [Abstract][Full Text] [Related]
19. Distinctive maturation of in vitro versus in vivo anti-CD40 mAb-matured dendritic cells in mice.
Frleta D; Lin JT; Quezada SA; Wade TK; Barth RJ; Noelle RJ; Wade WF
J Immunother; 2003; 26(1):72-84. PubMed ID: 12514431
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells stimulated with a bacterial product, OK-432, efficiently induce cytotoxic T lymphocytes specific to tumor rejection peptide.
Nakahara S; Tsunoda T; Baba T; Asabe S; Tahara H
Cancer Res; 2003 Jul; 63(14):4112-8. PubMed ID: 12874015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
